EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr | ₹84 Cr |
What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹498 Cr |
Mar2023 | ₹532 Cr |
Mar2022 | ₹662 Cr |
Mar2021 | ₹392 Cr |
Mar2020 | ₹84 Cr |
How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹498 Cr | -6.36 | |
Mar2023 | ₹532 Cr | -19.66 | |
Mar2022 | ₹662 Cr | 68.87 | |
Mar2021 | ₹392 Cr | 369.04 | |
Mar2020 | ₹84 Cr | - |
Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹20,743.6 Cr | 20.9% | 18.2% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 20.9% |
18.2% |
|
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses